Back

Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors mediate marked visual restoration

NISHIGUCHI, K. M.; Fujita, K.; Miya, F.; Katayama, S.; Nakazawa, T.

2019-12-01 bioengineering
10.1101/552653 bioRxiv
Show abstract

The most versatile treatment for inherited disorders is to precisely replace a mutated sequence with its wildtype counterpart, thereby "normalizing" the genome. We developed a single AAV platform that allows this in retinal neurons with combined CRISPR-Cas9 and micro-homology-mediated end-joining. In blind mice, the platform rescued ~10% of the retinal neurons, resulting in an incredible ~10,000-fold improvement in light sensitivity, equivalent to the restoration mediated by conventional gene augmentation therapy.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.